Gynecological Malignancies
Conditions
Interventions
Control group:The common mode
experimental group:Adopting the mode of "relief and advancing" for disease notification.
Sponsors
Guangdong Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with gynecological malignancies and staged as I-IV; 2. Patients with normal cognitive ability; 3. Patients and their families understand and are willing to participate in this study, and voluntarily sign the informed consent; 4. Patients with ECOG score <= 2; 5. Patients aged 18 to 65 years; 6. Patients with predicted survival more than 3 months.
Exclusion criteria
Exclusion criteria: 1. Patients or family members who have suffered from mental illness in the past or present; 2. Patients with rapid disease progression, poor prognosis, and only palliative treatment; 3. Patients who stop or give up treatment in the middle; 4. Accompanied by severe cardiovascular and cerebrovascular diseases and primary diseases of the lung, liver, kidney and other systems.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient's condition notification rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety, depression, and sleep scores of patients and entrusted family members;The patient's pain, pain, ECOG score; | — |
Countries
China
Contacts
Public ContactZhou Lili
Guangdong Provincial Hospital of Traditional Chinese Medicine
Outcome results
None listed